AI Insight
Researchers discovered that genetic mutations in collagen-related genes can trigger a cascade leading to spinal disc calcification and fusion in zebrafish, mirroring human degenerative disc disease. When scientists treated affected zebrafish with an osteoporosis medication and interventions targeting fat metabolism, they successfully reduced the mineral buildup and spinal damage. This study identifies previously unknown molecular pathways in disc degeneration and suggests existing drugs could be repurposed for treatment.
Why it matters
The findings offer potential new treatment approaches for degenerative disc disease and chronic back pain using medications already approved for human use. By identifying the genetic and metabolic mechanisms behind disc calcification, this research opens multiple therapeutic avenues that could be tested more rapidly than developing entirely new drugs.
Understand the Science
Genetic changes may set off a chain reaction that causes the spine’s natural shock absorbers to harden and deteriorate. Zebrafish with a faulty collagen-related gene developed mineral buildup and spinal fusion similar to human disc disease. Researchers were able to reduce the damage using an existing osteoporosis drug and by targeting fat metabolism. The discovery points to several exciting possibilities for future back pain treatments.
Source: A drug already used for osteoporosis blocked spinal damage in a new study